aTyr Pharma Stock Price

0.21 (4.83%)
Upgrade to Real-Time
Regular Market
Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
Small Cap Pro
Monthly Subscription
for only
DDE w/Realtime (Monthly)
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
aTyr Pharma Inc LIFE NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.21 4.83% 4.56 12:17:48
Open Price Low Price High Price Close Price Prev Close
4.58 4.41 4.6929 4.35
Bid Price Ask Price Spread News
4.54 4.58 0.04 - -
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
827 146,300 $ 4.54 $ 664,456 1,382,427 2.13 - 8.33
Last Trade Time Type Quantity Stock Price Currency
12:18:21 1,500 $ 4.56 USD

aTyr Pharma Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 46.45M 10.19M 9.41M $ 422.00k $ - -7.29 -1.60
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% - -

more financials information »

aTyr Pharma News

Date Time Source News Article
2/25/202108:00GlobeNewswire Inc.aTyr Pharma to Present at March Investor Conferences
2/17/202106:11Edgar (US Regulatory)Statement of Ownership (sc 13g)
2/16/202111:22Edgar (US Regulatory)Statement of Ownership (sc 13g)
2/16/202106:24Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)
2/12/202113:18Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)
2/11/202108:00GlobeNewswire Inc.aTyr Pharma Announces New tRNA Synthetase Discovery Programs
2/11/202106:08Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical LIFE Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week5.405.594.224.83553,164-0.84-15.56%
1 Month3.738.333.616.281,921,5610.8322.25%
3 Months4.498.333.485.321,445,6370.071.56%
6 Months3.758.332.935.20702,4140.8121.6%
1 Year3.798.332.134.90418,6720.7720.32%
3 Years41.3043.402.138.01392,483-36.74-88.96%
5 Years63.0090.94262.1316.74300,001-58.44-92.76%

aTyr Pharma Description

aTyr Pharma Inc is a biotherapeutics company engaged in the discovery and development of innovative medicines based on novel immunological pathways. Its focus is on the extracellular functionality and signaling pathways of tRNA synthetases. It's lead clinical product candidate, ATYR1923, is a selective modulator of Neuropilin-2 (NRP2) that downregulates both the innate and adaptive immune responses in inflammatory disease states. It is developing ATYR1923 as a potential disease-modifying therapy for patients with interstitial lung diseases (ILDs), a group of rare immune-mediated disorders that cause progressive fibrosis of the lung interstitium and remain a high unmet medical need.
Your Recent History
aTyr Pharm..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20210301 17:33:45